CAV1 and metabolic dysfunction-associated steatotic liver disease: CAV-1 activates the hepatocyte FTL/FTH pathway and drives the conversion of Fe2+ to Fe3+, which in turn inhibits oxidative stress in hepatocytes and ultimately alleviates liver injury during the course of NAFLD (Deng et al., 2023).